Nevertheless, the new disappointment with DNL343 is another major disappointment to ALS patients, who have limited drug ...

Big data is transforming this approach by providing healthcare organisations with a deeper understanding of patient ...

The results of the Intuition Brain Health study – sponsored by Biogen and supported by Apple – show the feasibility of using ...

Johns Hopkins surgeon and writer Dr Martin Makary, President Donald Trump's pick to lead the FDA, faced a grilling today by ...

The company confirmed this morning that NICE has taken the "unusual decision" to hold a third appraisal committee meeting as ...

President Donald Trump's nominee for NIH director, Dr Jay Bhattacharya, fielded intense questioning on vaccines and cuts to ...

XRHealth has made its second acquisition in the space of a few months, buying digital therapeutics (DTx) company RealizedCare ...

Novo Nordisk has launched a direct-to-consumer (DTC) option for uninsured or under-insured people wanting to access its GLP-1 ...

Just days after NHS England chief executive Amanda Pritchard tendered her resignation, national medical director Prof Sir ...

Giuseppe Accogli became the Group CEO of Chiesi Pharmaceuticals in 2023. With a 25-year career in the med-tech industry, he ...

It takes around seven years to develop a new drug and bring it to market. With the advent of GenAI, businesses in the life ...

Anderson is expecting 2025 to be a pivotal year for his turnaround plan – which revolves around the removal of management ...